When Shannon Linker went to work for the Arts Council of Indianapolis in mid-2002, it was a typical pass-through organization–re-granting
city money to local arts groups. Now Linker is director of an artist-services program for the council that is on par with
those offered in communities like Seattle and New York City but few other places.
Shares of Targanta Therapeutics Inc. fell 7.5 percent yesterday in the company’s first day as a public company. The stock closed at $9.25 a share after opening at $10, the price sought in the $57 million initial public offering. Targanta is listed on NASDAQ under the ticker TARG. The Cambridge, Mass., firm is commercializing an […]
Many analysts are recommending that investors hold off on buying stock in Novo Nordisk because rival Eli Lilly and Co. might encounter a smash hit with a version of its Byetta diabetes treatment that would be taken only once a week. Nineteen of the 34 analysts who follow the Danish insulin maker have “hold” or […]
If you look at stock market returns over a 100-year-plus time frame, the highestreturning industries have been pharmaceuticals and cosmetics. Dropping the time frame down to the last 25 years shows a different picture, with technology taking the top spot. But with more than a century of momentum, drug companies can still attract interest. Using a quantitative screen that I run every week, I noticed that biotechnology stocks have been picking up steam lately. This surprised me because the big…
What began in 1994 as a six-room schoolhouse with 38 students has grown into a three-building campus with 602 pupils. The growth of the International School of Indiana, which welcomed a new headmaster this year, has been possible because of increased support from an expanding flock of businesses. They believe in its mission: to help attract scientists and executives from around the world to this community by providing a global education for their children. Before the school opened, recalled Eli…
Eli Lilly and Co. today said it would plow ahead with plans to develop an inhaled insulin product even as competitor Pfizer Inc. announced it would stop making its poor-selling Exubera version. Lilly President and Chief Operating Officer made the comment while discussing the Indianapolis drugmaker’s third-quarter results. Profit was up 6 percent, to $926.3 […]
Indianapolis-area companies are ponying up $1.15 million to help put on this month’s National FFA convention, an event expected to draw more than 55,000 members and their chaperones to the city. They’re backing the bigbudget affair largely because of the access it gives them to future leaders-from tomorrow’s policymakers to those who could someday work at these local firms. And the city is putting on quite a show to get the attention of the roughly 46,000 12-to 21-year-old members and…
Analysts and investors turned sour on Eli Lilly and Co.’s stock overnight after the Indianapolis drug maker stopped enrolling patients in two small safety trials of a potential blockbuster drug. Lilly shares opened today at $52.15, down $3.74 or 6.6 percent from their close yesterday. Lilly announced yesterday after markets closed that it had temporarily […]
WellPoint Inc. and Angie’s List are both racing to launch doctor-rating services early next year. But Angie’s List is already
sour over Well-Point’s decision to partner with New York-based Zagat Survey LLC for its doctor-rating service, apparently
without talking to Angie’s List.
Eli Lilly and Co has agreed to buy rights to an experimental compound for the treatment of various pains, including pain associated with osteoarthritis, from Glenmark Pharmaceuticals Ltd India. Lilly will pay a $45 million upfront fee as well as up to $215 million more in potential development and sales milestones, plus royalties. The compound, […]
HemaQuest Pharmaceuticals, a startup in Newton, Mass., said today it has received $20 million in funding from Lilly Ventures, De Novo Ventures of Palo Alto, Calif.; and Forward Ventures of San Diego. The amount of the investment by Lilly Ventures, the venture capital arm of Indianapolis-based Eli Lilly and Co., wasn’t specified. HemaQuest is developing […]
There’s a $2 billion hole in Eli Lilly and Co.’s future. That’s roughly how much pretax profit Lilly derives each year from
its best-seller, Zyprexa, according to calculations by IBJ. And it’s how much black ink will start running off Lilly’s books
once Zyprexa’s U.S. and European patents expire in 2011.
If the idea of building a $50 million, 7-1/2-mile pedestrian and biking trail through the streets of downtown Indianapolis
is indeed crazy, Brian Payne might be considered the Indianapolis Cultural trail’s mad scientist. His leadership, persistence
and passion for the project are the key reasons the first leg of the trail is due to open this month along Alabama Street.
After reporting mixed results on a potentially lucrative blood thinner, Eli Lilly and Co. plans a new late-stage test of prasugrel for patients not receiving stents to open clogged heart arteries. Lilly and its development partner, Daiichi Sankyo Co. Ltd., plan to submit the drug for regulatory approval before the end of this year; the […]
Indianapolis-based Technuity Inc. has been acquired by Audiovox Corp. of Hauppauge, N.Y., for $16.5 million, plus repayment of $4 million in debt. The deal closed Nov. 1, Audiovox announced today. Technuity is the exclusive North American licensee of Energizer Power Protection products and Energizer rechargeable batteries and accessories. About 30 people are employed at its […]
Two weeks ago, the NAACP backed existing and former black employees of Indianapolis-based Eli Lilly and Co. in a lawsuit that claims they were treated unfairly. Today, the National Urban League bestowed its Corporate Leadership Award on the pharmaceutical maker for working with the Urban League-also a civil rights group-to sponsor a program that encourages […]
The National Urban League gave Eli Lilly and Co. its highest corporate honor today for helping with a health
outreach program to African-Americans.
Just two weeks ago another venerable civil rights group, the NAACP, backed a lawsuit filed for current and…
Entertainment is a big part of a $480 million development proposed for the south side of downtown–plans include a 3,400-seat
theater to attract the likes of Bruce Springsteen and first-run tours of Broadway shows such as “Wicked.” The question is
whether the city can support another midsize venue.
Ten times a year, for 24 hours, a select group of executives leaves the comforts of career to embark on an experience meant to mold the participants into better leaders. They gather on Thursday evenings for dinner, bunk overnight at a hotel, and spend the following day listening to the likes of Dennis Perkins, author of “Leading at the Edge: Leadership Lessons from the Extraordinary Saga of Shackleton’s Antarctic Expedition.” Or, they may travel to Saint Meinrad in southern Indiana…
If Circle Centre mall were built today, it would cost $420 million. Throw in another $60 million, and you’ve got the price
of Legends District-SoDo, a proposed mixed-use development on the south edge of downtown.
